Drugs / Polyferose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT04975074 | Jul → Dec 2021 | iron deficiency anemia | Shengjing Hospital | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01425463 Comparator | Mar 2011 → Oct 2013 | iron deficiency anemia | Sanol GmbH | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | polyferose | “polyferose” NCT04975074 ↗ |
| Known as | Iron carbohydrate complex | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108525 ↗ |
| Modality | Small molecule | — CHEMBL2108525 ↗ |
| Route | Oral | “Administered orally with water.” NCT01425463 ↗ |